This report summarises performance during quarter four (1 April – 30 June 2024) and is the last against expectations set out in the Interim New Zealand Health Plan | Te Pae Tata and the 2023/24 Statement of Performance Expectations. Read more
Lived experience of affordability as a barrier to prescription medicines: A longitudinal qualitative study
Exploring lived experience provides insights into the multiple ways that lack of affordability prevents access to medicines: directly, through interaction with other barriers to access including transport, by damaging trust and reducing acceptability of services, and by making participants less able to deal with mistakes made by health professionals.